Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
株式のランク #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
株価
$2.10
最終同期: 2026-08-21
時価総額
$104.43M
変化(1日)
-2.10%
変化(1年)
-
US
取引 Polaryx Therapeutics, Inc. Common Stock (PLYX)

カテゴリー

Polaryx Therapeutics, Inc. Common Stock(PLYX)の配当利回りの履歴
Polaryx Therapeutics, Inc. Common Stock(銘柄コード: PLYX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Polaryx Therapeutics, Inc. Common Stock(PLYX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)